Dapoxetine for premature ejaculation

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 1, 2011, Pages 125-128

  Feige, A M ^a   Pinsky, M R ^a   Hellstrom, W J G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPOXETINE; PLACEBO; PRILIGY; UNCLASSIFIED DRUG;

ARTICLE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISTRESS SYNDROME; DIZZINESS; DRUG EFFECT; DRUG HALF LIFE; DRUG WITHDRAWAL; FRUSTRATION; HEADACHE; HUMAN; MALE SEXUAL DYSFUNCTION; NAUSEA; PREMATURE EJACULATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; BENZYLAMINES; EJACULATION; HUMANS; MALE; NAPHTHALENES; PROTEIN ISOFORMS; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 78650516442     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.215     Document Type: Article

References (30)

1. Laumann, E.O., Paik, A. & Rosen, R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537-544 (1999). (Pubitemid 29081307)
2. American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn.-text revision (american Psychiatric association, Washington, DC, 2000).
3. McMahon, C.G. et al.; International Society for Sexual Medicine ad Hoc Committee for Defnition of Premature Ejaculation. An evidence-based defnition of lifelong premature ejaculation: report of the International Society for Sexual Medicine ad Hoc Committee for the Defnition of Premature Ejaculation. BJU Int. 102, 338-350 (2008).
4. Waldinger, M.D. Recent advances in the classifcation, Neurobiology and treatment of premature ejaculation. Adv. Psychosom. Med. 29, 50-69 (2008).
5. Kendirci, M., Salem, E. & Hellstrom, W.J.G. Dapoxetine, A novel selective serotonin reuptake inhibitor for the treatment of premature ejaculation. Ther. Clin. Risk Manag. 3, 277-289 (2007).
6. Giuliano, F. & Hellstrom, W.J. The pharmacological treatment of premature ejaculation. BJU Int. 102, 668-675 (2008).
7. Hellstrom, W.J. Emerging treatments for premature ejaculation: focus on dapoxetine. Neuropsychiatr. Dis. Treat. 5, 37-46 (2009).
8. Patrick, D.L. et al. Premature ejaculation: an observational study of men and their partners. J. Sex. Med. 2, 358-367 (2005).
9. Porst, H. et al. Impact of premature ejaculation (PE) on female partners: results from a 5-country European observational study. Eur. Urol. Suppl. 7, 186 (2008).
10. Patel, K. & Hellstrom, W.J. Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation. Curr. Opin. Investig. Drugs 10, 681-690 (2009).
11. Holstege, G., Georgiadis, J.R., Paans, A.M., Meiners, L.C., Van der Graaf, F.H. & Reinders, A.A. Brain activation during human male ejaculation. J. Neurosci. 23, 9185-9193 (2003).
12. Marson, L. & McKenna, K.E. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual refexes. Exp. Brain Res. 88, 313-320 (1992).
13. Kim, S.C., Seo, K.K., Han, J.H. & Lee, M.Y. Inhibitory efect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study. J. Urol. 163, 1988-1991 (2000).
14. Kim, S.W., Lee, S.H. & Paick, J.S. In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously. Int. J. Impot. Res. 16, 427-432 (2004).
15. Morales, A., Barada, J. & Wyllie, M.G. A review of the current status of topical treatments for premature ejaculation. BJU Int. 100, 493-501 (2007).
16. Busato, W. & Galindo, C.C. Topical anaesthetic use for treating premature ejaculation: a double-blind, Randomized, Placebo-controlled study. BJU Int. 93, 1018-1021 (2004).
17. Montejo, A.L., Llorca, G., Izquierdo, J.A. & Rico-Villademoros, F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J. Clin. Psychiatry 62 (suppl. 3), 10-21 (2001).
18. Gengo, P.J. et al. Monoaminergic transporter binding and inhibition profle of dapoxetine, A medication for the treatment of premature ejaculation. J. Urol. 173, 239 (2005).
19. Modi, N.B., Dresser, M.J., Simon, M., Lin, D., Desai, D. & Gupta, S. Single-and multiple-dose pharmacokinetics of dapoxetine hydrochloride, A novel agent for the treatment of premature ejaculation. J. Clin. Pharmacol. 46, 301-309 (2006).
20. Hiemke, C. & Härtter, S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 85, 11-28 (2000).
21. Lakemedelsverket Medical Products agency. Public assessment Report: Scientifc Discussion Priligy Dapoxetine Hydrochloride Film-coated Tablets, 30 and 60 mg (December 2008).
22. Waldinger, M.D., Zwinderman, A.H., Olivier, B. & Schweitzer, D.H. Proposal for a defnition of lifelong premature ejaculation based on epidemiological stopwatch data. J. Sex. Med. 2, 498-507 (2005).
23. Pryor, J.L. et al.; Dapoxetine Study Group. Efcacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, Randomised controlled trials. Lancet 368, 929-937 (2006).
24. Kaufman, J.M., Rosen, R.C., Mudumbi, R.V., Tesfaye, F., Hashmonay, R. & Rivas, D. Treatment beneft of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int. 103, 651-658 (2009).
25. Buvat, J., Tesfaye, F., Rothman, M., Rivas, D.A. & Giuliano, F. Dapoxetine for the treatment of premature ejaculation: results from a randomized, Double-blind, Placebo-controlled phase 3 trial in 22 countries. Eur. Urol. 55, 957-967 (2009).
26. McMahon, C. et al.; Dapoxetine 3003 Study Investigators. Treatment of premature ejaculation in the asia-Pacifc region: results from a phase III double-blind, Parallel-group study of dapoxetine. J. Sex. Med. 7, 256-268 (2010).
27. Giuliano, F. et al. Lack of withdrawal syndrome or efects on anxiety with dapoxetine (DPX) for the treatment of premature ejaculation (PE): results from 2 phase III trials. Eur. Urol. Suppl. 7, 465 (2008).
28. Casey, R., Tesfaye, F., Mudumbi, R., Rothman, M. & Rivas, D. Efects of dapoxetine (DPX) for the treatment of premature ejaculation (PE) on the erectile function and scales of mood and afect. Eur. Urol. Suppl. 7, 463 (2008).
29. Looney, C., Thor, K.B., Ricca, D. & Marson, L. Diferential efects of simultaneous or sequential administration of paroxetine and Way-100,635 on ejaculatory behavior. Pharmacol. Biochem. Behav. 82, 427-433 (2005).
30. Safarinejad, M.R. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, Placebo-controlled and randomized study. J. Clin. Psychopharmacol. 28, 39-44 (2008).